These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25069257)

  • 1. [Reconsideration of nicotine and other substance dependence: a clue from dependence-related mentation including reward, motivation, learning, delusion and hallucination toward understanding the concept of non-substance-related addiction].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):191-7. PubMed ID: 25069257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic decreases in brain reward function during nicotine withdrawal.
    Epping-Jordan MP; Watkins SS; Koob GF; Markou A
    Nature; 1998 May; 393(6680):76-9. PubMed ID: 9590692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward.
    von der Goltz C; Koopmann A; Dinter C; Richter A; Rockenbach C; Grosshans M; Nakovics H; Wiedemann K; Mann K; Winterer G; Kiefer F
    Psychoneuroendocrinology; 2010 May; 35(4):570-7. PubMed ID: 19828259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of nicotine withdrawal: intracranial self-stimulation and somatic signs of withdrawal.
    Bauzo RM; Bruijnzeel AW
    Methods Mol Biol; 2012; 829():257-68. PubMed ID: 22231819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cued for risk: Evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior.
    Hellberg SN; Russell TI; Robinson MJF
    Cogn Affect Behav Neurosci; 2019 Jun; 19(3):737-758. PubMed ID: 30357661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histidine triad nucleotide binding 1 protein is involved in nicotine reward and physical nicotine withdrawal in mice.
    Jackson KJ; Wang JB; Barbier E; Damaj MI; Chen X
    Neurosci Lett; 2013 Aug; 550():129-33. PubMed ID: 23810802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of nicotine dependence].
    Miyata H; Yanagita T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1998 Oct; 33(5):557-73. PubMed ID: 9844376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature.
    DiFranza JR; Wellman RJ
    Nicotine Tob Res; 2005 Feb; 7(1):9-26. PubMed ID: 15804674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpharmacologic approaches to substance abuse treatment.
    Carroll KM; Schottenfeld R
    Med Clin North Am; 1997 Jul; 81(4):927-44. PubMed ID: 9222261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine.
    Paterson NE
    Behav Pharmacol; 2009 May; 20(3):211-25. PubMed ID: 19421028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Control of craving for methamphetamine: development of scales for dependence and search for medicines for treatment].
    Ogai Y; Haraguchi A; Kondo A; Takamatsu Y; Yamamoto H; Sendoo E; Ikeda K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Oct; 25(5):227-33. PubMed ID: 16313099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychological aspects of nicotine craving].
    Muñoz MÁ; Sanjuan R; Fernández-Santaella MC; Vila J; Montoya P
    Adicciones; 2011; 23(2):111-23. PubMed ID: 21647542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco addiction: a biochemical model of nicotine dependence.
    Ortells MO; Barrantes GE
    Med Hypotheses; 2010 May; 74(5):884-94. PubMed ID: 19962246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression changes in a zebrafish model of drug dependency suggest conservation of neuro-adaptation pathways.
    Kily LJ; Cowe YC; Hussain O; Patel S; McElwaine S; Cotter FE; Brennan CH
    J Exp Biol; 2008 May; 211(Pt 10):1623-34. PubMed ID: 18456890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on clinical features of nicotine dependence in comparison with those of alcohol and methamphetamine dependence using a two compartment model of drug dependence].
    Kono J; Miyata H; Yanagita T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):29-42. PubMed ID: 12690639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterase inhibitors might alleviate methamphetamine-induced delusions, hallucinations and cognitive impairment, while reducing craving and addiction.
    Alisky JM
    World J Biol Psychiatry; 2006; 7(4):269. PubMed ID: 17071550
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurobiological mechanisms of nicotine craving.
    Miyata H; Yanagita T
    Alcohol; 2001 Jun; 24(2):87-93. PubMed ID: 11522428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco smoking in schizophrenia: investigating the role of incentive salience.
    Freeman TP; Stone JM; Orgaz B; Noronha LA; Minchin SL; Curran HV
    Psychol Med; 2014 Jul; 44(10):2189-97. PubMed ID: 24176189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calcium channel antagonists on the motivational effects of nicotine and morphine in conditioned place aversion paradigm.
    Budzynska B; Polak P; Biala G
    Behav Brain Res; 2012 Mar; 228(1):144-50. PubMed ID: 22178315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.